Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Legend Biotech CorpLEGN · Entity 4033 | Chief Executive Officer | September 15, 2026 | September 16, 2026 |
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | Director | November 11, 2025 | November 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Legend Biotech Corp
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,131,860 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 1,131,860 · Balance 1,131,860 F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
METTLER TOLEDO INTERNATIONAL INC/
Report date November 11, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 207 |
Reported balance
After 2025-11-11 transaction · row 1
1 source rowRow 1 · 2025-11-11 · Grant · Acquired 63 · Balance 207 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,445.06 · Expires 2035-11-11 | Direct | 162 |
Reported balance
After 2025-11-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-11 · Grant · Acquired 162 · Balance 162 F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:18 UTC | Legend Biotech Corp LEGN · Entity 4033 | GrantOrdinary Shares | 1,131,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001964342-26-000004 · form4-09162026_080948.xml · nonDerivative · entry 1 Zhang Ingrid · CIK 0001964342 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,131,860 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:06 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 162 | $0.00 Strike: $1,445.06 | $0.00 |
DisclosureSEC source: 0001037646-25-000086 · form4.xml · derivative · entry 2 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162 Underlying: Common Stock, par value $0.01 per share · 162 shares Expires 2035-11-11 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:06 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001037646-25-000086 · form4.xml · nonDerivative · entry 1 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207 Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 18:31 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 182 | $0.00 Strike: $1,260.97 | $0.00 |
DisclosureSEC source: 0001062993-24-019107 · form4.xml · derivative · entry 2 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182 Underlying: Common Stock, par value $0.01 per share · 182 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 18:31 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019107 · form4.xml · nonDerivative · entry 1 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144 Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 13:59 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 250 | $0.00 Strike: $1,024.55 | $0.00 |
DisclosureSEC source: 0001062993-23-020536 · form4.xml · derivative · entry 2 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock, par value $0.01 per share · 250 shares Expires 2033-11-09 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 13:59 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-020536 · form4.xml · nonDerivative · entry 1 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73 Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:41 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 140 | $0.00 Strike: $1,560.54 | $0.00 |
DisclosureSEC source: 0001062993-23-002070 · form4.xml · derivative · entry 2 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Underlying: Common Stock, par value $0.01 per share · 140 shares Expires 2033-02-01 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:41 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-002070 · form4.xml · nonDerivative · entry 1 Zhang Ingrid · CIK 0001964342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.